References
- Robert-Koch Institut. Gesellschaft der epidemiologischen Krebsregister in Deutschland/Krebs in Deutschland 2005–2006, Häufigkeiten und Trends.Niere.2010;6:80–3.
- DringsP, WannenmacherM, StamatisG. Nichtkleinzellige Bronchialkarzinome. In: Seeber S, Schütte J, editors. Therapiekonzepte Onkologie. Berlin/Heidelberg/New York: Springer-Verlag; 2003. p.675–712.
- MirsadraeeS, OswalD, AlizadehY. The 7th lung cancer TNM classification and staging system: review of the changes and implications.World J Radiol.2012;4(4):128–34.
- GoeckenjanG, SitterH, ThomasG. Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society.Pneumologie.2011;65:5–75.
- CaanB, SternfeldB, GundersonE. Life after Cancer Epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States).Cancer Causes Control.2005;16(Suppl 5):545–56.
- KirschnerJ, KolbM, MüllerJ. Undesirable (cardiovascular) side effects of vinorelbin in non-small cell bronchial carcinoma.Pneumologie.2000;54:54–7.
- NesmeP, Trillet-LenoirV, BruneJ. Infarctus du myocarde induit par la vinorelbine?Cah Oncol.1993;2:237–8.
- BergeronA, RaffyO, VannetzelJM. Myocardial ischemia and infarction associated with vinorelbine.J Clin Oncol.1995;13(Suppl 2):531–2.
- RaymondE, GoldwasserF, EspieM. The cardiotoxicity of vinorelbine.Cancer Res Ther Control.1994;4(Suppl 21):87–8.
- Mouchard-DelmasC, Devie-HubertI, DuferJ. Effects of the anticancer agent vinorelbin on endothelial cell permeability and tissue factor production in man.J Pharm Pharmacol.1996;48:951–4.
- SedlacekHH. Onkologie — die Tumorerkrankungen des Menschen. Berlin: De Gruyter; 2012.
- MooeT, ErikssonP, StegmayrB. Ischemic stroke after acute myocardial infarction — a population-based study.Stroke.1999;28:762–7.
- Fachinformation Navelbine. Available from: http://www.detect-studien.de/downloads/fachinfo/Navelbine.pdf
- Open Drug Database. Available from: http://ch.oddb.org/de/gcc/fachinfo/reg/58278